Our Highlighted Trials & Studies
Post-Transplant Drug Study for ALL and NHL
Investigational Therapy to Reprogram Patient’s Immune Response to Cancer Cells
Efficacy & Safety Drug Study for Patients with Primary Immune Thrombocytopenia (ITP)
Research resources we offer for clinicians in the field of hematologic malignancies include the following:
- Innovations in Clinical Trials: This publication highlights the work of clinicians and researchers at UH who are making significant strides in the treatment of hematologic malignancies.
- Physician research publications: Our physicians are dedicated to advancing care for hematologic malignancies through leading-edge research studies. Read more about the published work of our physician-scientists.